Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: a report of 3 cases [0.03%]
利托那韦增强的达芦那韦与非核苷类逆转录酶抑制剂间的药动学相互作用:3例报道
Holly E Rawizza,Paul E Sax
Holly E Rawizza
Pharmacokinetic interactions among antiretroviral agents may influence the potency or toxicity of coadministered drugs. Here we present 3 patients with extensive protease inhibitor and NRTI resistance for whom ritonavir-boosted darunavir (D...
Mariana M Cajaiba,Bruce J Dezube,Liron Pantanowitz
Mariana M Cajaiba
Case Reports
The AIDS reader. 2008 Sep;18(9):458-60. DOI: 2008
Duane M Smith
Duane M Smith
Case Reports
The AIDS reader. 2008 Sep;18(9):453-5. DOI: 2008
Compartmentalizing AIDS [0.03%]
隔离艾滋病
Jeffrey Laurence
Jeffrey Laurence
Editorial
The AIDS reader. 2008 Sep;18(9):451-2. DOI: 2008
Editorial comment: neuropsychiatric aspects of HIV/HCV coinfection--what every HIV care provider needs to know and address [0.03%]
述评:艾滋病与丙肝病毒共感染的相关神经精神症状——每一位艾滋病防治人员都需要了解和处理的问题
Glenn J Treisman
Glenn J Treisman
Editorial
The AIDS reader. 2008 Aug;18(8):440-1. DOI: 2008